Biopharmaceutical Scientists specialize in the development and production of biologically-based medicines, including therapeutic proteins, antibodies, and vaccines, derived from living organisms. Their work involves understanding the molecular mechanisms of diseases and designing biologics that can interact with the body to treat or prevent them. These scientists work with complex biologic molecules, ensuring they are stable, effective, and safe for human use. From early-stage discovery to large-scale manufacturing, biopharmaceutical scientists employ advanced techniques like recombinant DNA technology, cell culture, and protein engineering to develop new treatments. Their expertise is essential in the development of innovative therapies for conditions that are difficult to treat with traditional pharmaceuticals, such as autoimmune diseases and cancer.
Biopharmaceutical scientists are also responsible for optimizing production processes and ensuring regulatory compliance. They collaborate with regulatory agencies, quality control teams, and manufacturing experts to scale up production and ensure that products meet strict safety and efficacy standards. As biologic therapies become increasingly common, these scientists are pushing the boundaries of medicine by developing personalized and targeted treatments that offer more precise and effective solutions for patients. Their research continues to be pivotal in shaping the future of healthcare, offering hope for patients with conditions that previously had limited treatment options. With the rise of biologics, biopharmaceutical scientists are at the forefront of modern medicine, driving breakthroughs that will impact global healthcare for years to come.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada